Literature DB >> 18984013

Molecular characterization and expression analysis of a P-glycoprotein homologue in Toxoplasma gondii.

Aline Schmid1, Virginie Sauvage, Sandie Escotte-Binet, Dominique Aubert, Christine Terryn, Roselyne Garnotel, Isabelle Villena.   

Abstract

ATP-binding cassette (ABC) transporters represent an important family of membrane proteins involved in drug resistance and other biological activities. The present study reports on the characterization of a P-glycoprotein (Pgp), TgABC.B1, in the protozoan parasite Toxoplasma gondii. The protein encoded by the TgABC.B1 gene displays the typical (TMD-NBD)2 structural organization of the "full" ABC transporter and shows significant identity and similarity with two apicomplexan Pgps; Pgh1 in Plasmodium falciparum and CpABC3 in Cryptosporidium parvum. The TgABC.B1 gene is a single copy gene transcribed into a full-length mRNA of 4.3kb and expressed as a protein of approximately 150kDa, which cellular localization revealed a membrane-associated labelling in tachyzoites. The TgABC.B1 gene is constitutively expressed in the three major T. gondii genotypes but demonstrated a higher expression in virulent type I, at both transcriptional and translational levels. Further characterization of this Pgp-like protein will increase our knowledge of the membrane transport system in this parasite and could result in the identification of a new therapeutic target in Toxoplasma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984013     DOI: 10.1016/j.molbiopara.2008.09.010

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  5 in total

1.  The P-glycoprotein inhibitor GF120918 modulates Ca2+-dependent processes and lipid metabolism in Toxoplasma gondii.

Authors:  Iveta Bottova; Ursula Sauder; Vesna Olivieri; Adrian B Hehl; Sabrina Sonda
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

2.  Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice.

Authors:  Joachim Müller; Adriana Aguado-Martinez; Vera Manser; Vreni Balmer; Pablo Winzer; Dominic Ritler; Isabel Hostettler; David Arranz-Solís; Luis Ortega-Mora; Andrew Hemphill
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-02-13       Impact factor: 4.077

3.  Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil.

Authors:  Letícia Azevedo Silva; João Luís Reis-Cunha; Daniella Castanheira Bartholomeu; Ricardo Wagner Almeida Vítor
Journal:  PLoS One       Date:  2017-01-24       Impact factor: 3.240

4.  Sulfadiazine resistance in Toxoplasma gondii: no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters.

Authors:  Christelle Doliwa; Sandie Escotte-Binet; Dominique Aubert; Virginie Sauvage; Frédéric Velard; Aline Schmid; Isabelle Villena
Journal:  Parasite       Date:  2013-05-27       Impact factor: 3.000

5.  P-Glycoprotein Inhibitors Differently Affect Toxoplasma gondii, Neospora caninum and Besnoitia besnoiti Proliferation in Bovine Primary Endothelial Cells.

Authors:  Camilo Larrazabal; Liliana M R Silva; Learta Pervizaj-Oruqaj; Susanne Herold; Carlos Hermosilla; Anja Taubert
Journal:  Pathogens       Date:  2021-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.